Scoping Review of Hormonal Contraception and Psychiatric Outcomes, 2014-2024

46 peer-reviewed studies published between 2014 and 2024 were analyzed in this scoping review. The review, authored by Amélie Poirier, examines associations between hormonal contraceptive use and psychiatric outcomes like depressive symptoms, anxiety, and suicidality. It includes a meta-analysis and was last updated in June 2026.

Use Cases

• Conducting meta-analyses on the association between progestin-only contraceptives and depressive symptoms based on the reported risk ratios.
• Investigating methodological heterogeneity in psychiatric outcome measurement across contraceptive studies as noted in the review.
• Informing clinical guidelines for mental health screening in contraceptive counseling based on the review's findings and discussion.
• Identifying research gaps for future prospective studies on hormonal contraception and anxiety outcomes, given the inconsistent evidence highlighted.

Strengths

• Analysis is based on 46 identified studies meeting inclusion criteria.
• Includes a random-effects meta-analysis with specific risk ratios and confidence intervals (e.g., RR=1.24 for depressive symptoms).
• Study quality was assessed using the Joanna Briggs Institute checklist.

Limitations

• The dataset is a 688.2 KB document; the underlying data tables and row counts are not directly accessible.
• Column-level documentation is absent; field semantics must be inferred after download.
• Methodological heterogeneity in outcome measurement and control for confounding was noted as a frequent limitation in the source studies.

Provenance

Source

figshare, author Amélie Poirier

Collection Method

Scoping review and meta-analysis of peer-reviewed literature from four major databases.

Time Range

Studies published between 2014 and 2024

Freshness

Last updated 2026-06-01 05:25:23